Tag: Completes

Japan – MHIAEL Completes Expansion of the its Nagasaki Plant for Manufacture of Aero Engine Combustors

Mitsubishi Heavy Industries Aero Engines, Ltd., a part of Mitsubishi Heavy Industries (MHI) Group has completed the expansion of its Nagasaki Plant, an aero engine component factory located on the premises of MHI’s Nagasaki Shipyard & Machinery Works (Akunoura-cho, Nagasaki). This is the expansion of first building of MHIAEL Nagasaki Plant which is under operation now and the newly expanded facility with sequentially added equipment will allow MHI to meet the growing demand for the engine components produced at this plant for short and medium range commercial aircraft. In addition, the introduction of Japan’s first thermal barrier coating equipment for ... Read more

Japan – Eisai Completes Submission of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease to the U.S. FDA

Eisai Co., Ltd. and Biogen Inc. announced today that Eisai submitted to the U.S. Food andDrug Administration (FDA) a Supplemental Biologics License Application (sBLA) for monthly lecanemab-irmb (U.S. brand name: LEQEMBI) intravenous (IV) maintenance dosing. LEQEMBI is indicated for the treatment of Alzheimer’s disease (AD) in patients with mild cognitive impairment or mild dementia stage of disease (collectively referred to as early AD). As part of the monthly IV maintenance regimen, the patients who have completed the biweekly IV initiation phase, exact period under discussion with the FDA, would receive a monthly IV dose that maintains effective drug concentration to ... Read more

Astellas Completes Acquisition of Propella Therapeutics

TOKYO – WEBWIRE – Friday, December 22, 2023 Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, Astellas) announced today that it has completed the acquisition of Propella Therapeutics, Inc. (President and CEO: William Moore, Propella), and has become a wholly owned subsidiary of Astellas as of U.S. Eastern Time December 21, 2023. Through the acquisition of Propella, Astellas has acquired PRL-02 (abiraterone decanoate), a next-generation androgen biosynthesis inhibitor being developed by Propella to treat prostate cancer. PRL-02 is a novel, long-acting prodrug* of abiraterone that, following intramuscular injection, is expected to achieve high concentrations in target tissues where ... Read more

SATORP completes MENA region’s first conversion of used cooking oil into ISCC+ certified sustainable aviation fuel (SAF)

Paris – WEBWIRE – Wednesday, November 1, 2023 SATORP, platform jointly owned by Aramco (62,5 %) and TotalEnergies (37,5 %), has for the first time in the region successfully converted used cooking oil through coprocessing into ISCC+ certified Sustainable Aviation Fuel (SAF). Last August, the platform successfully co-processed Used Cooking Oil in the Low-Pressure Hydrodesulphurization Unit (LPHDS), producing SAF, meeting all product quality parameters within the SAF specifications. TotalEnergies contributed thanks to its experience and expertise to this realization. SATORP has received International Sustainability and Carbon Certification (ISCC+) to produce SAF. With this certification, the platform will be able to ... Read more

Q2 Metals Completes NSR Buyback on the Mia Lithium Property, James Bay Territory, Quebec, Canada

Vancouver, British Columbia–(ACN Newswire – November 2, 2023) – Q2 Metals Corp. (TSXV: QTWO) (OTCQB: QUEXF) (FSE: 458) (“Q2” or the “Company“) is pleased to announce that it has entered into an agreement with 9219-8845 QC Inc., a private Quebec company dba Canadian Mining House (“CMH“) to buy back the 2% Net Smelter Production Royalty (the “NSR“) held by CMH on certain claims comprising the 100% owned Mia Lithium Property (the “Property“), located in the Eeyou Istchee James Bay Territory of Quebec, subject to customary closing conditions and the approval of the TSX Venture Exchange (“TSX-V“). The NSR is a ... Read more